Gene · 3202
Papers1,918
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,918
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Transcriptomic Investigation of Rett Syndrome Reveals Increasing Complexity Trends from Induced Pluripotent Stem Cells to Neurons with Implications for Enriched Pathways. | ACS Omega | 2023 | 38027357 | PubTator, text mining | PubMed |
| Entecavir: A Review and Considerations for Its Application in Oncology. | Pharmaceuticals (Basel) | 2023 | 38004468 | PubTator, text mining | PubMed |
| Molecular Linkage between Immune System Disorders and Atherosclerosis. | Curr Issues Mol Biol | 2023 | 37998729 | PubTator, text mining | PubMed |
| Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis. | J Transl Med | 2023 | 37978384 | PubTator, text mining | PubMed |
| Transfection of Vein Grafts with Early Growth Response Factor-1 Oligodeoxynucleotide Decoy: Effects on Stem-Cell Genes and Toll-like Receptor-Mediated Inflammation. | Int J Mol Sci | 2023 | 37958848 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood. | Cell Rep Med | 2023 | 37913777 | PubTator, text mining | PubMed |
| SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances. | Front Oncol | 2023 | 37909026 | PubTator, text mining | PubMed |
| TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling. | Cell Death Discov | 2023 | 37845209 | PubTator, text mining | PubMed |
| An interactive resource of molecular signalling in the developing human haematopoietic stem cell niche. | Development | 2023 | 37840454 | PubTator, text mining | PubMed |
| Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma? | Int J Mol Sci | 2023 | 37834206 | PubTator, text mining | PubMed |
| Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts. | Front Immunol | 2023 | 37822926 | PubTator, text mining | PubMed |
| An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy. | Aging (Albany NY) | 2023 | 37812190 | PubTator, text mining | PubMed |
| RNA Sequencing and Related Differential Gene Expression Analysis in a Mouse Model of Emphysema Induced by Tobacco Smoke Combined with Elastin Peptides. | Int J Chron Obstruct Pulmon Dis | 2023 | 37810372 | PubTator, text mining | PubMed |
| Functional Insight into and Refinement of the Genomic Boundaries of the JARID2-Neurodevelopmental Disorder Episignature. | Int J Mol Sci | 2023 | 37762546 | PubTator, text mining | PubMed |
| Investigating Neuron Degeneration in Huntington's Disease Using RNA-Seq Based Transcriptome Study. | Genes (Basel) | 2023 | 37761940 | PubTator, text mining | PubMed |
| Identification of Genes and miRNAs Associated with TAFI-Related Thrombosis: An in Silico Study. | Biomolecules | 2023 | 37759718 | PubTator, text mining | PubMed |
| [DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis]. | Mol Biol (Mosk) | 2023 | 37752647 | PubTator, text mining | PubMed |
| The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1. | Aging (Albany NY) | 2023 | 37737712 | PubTator, text mining | PubMed |
| Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective. | J Pharm Anal | 2023 | 37719197 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3202/papers?page=6